Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions By Jop de VriezeDec. 21, 2020
Largest ever research integrity survey flounders as universities refuse to cooperate By Jop de VriezeNov. 25, 2020
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some By Jop de VriezeNov. 18, 2020
‘It’s a tricky thing.’ COVID-19 cases haven’t soared in Nigeria, but that could change By Jop de VriezeJul. 14, 2020
Can a century-old TB vaccine steel the immune system against the new coronavirus? By Jop de VriezeMar. 23, 2020
First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concerns By Jop de VriezeNov. 26, 2019
Podcast: Do scientists make great contributions after 30? We chat with experts about some common scientific myths By Sarah Crespi, Jop de VriezeSep. 20, 2018
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy By Jop de VriezeSep. 18, 2018
Open-access journal editors resign after alleged pressure to publish mediocre papers By Jop de VriezeSep. 4, 2018
Trials of impotence drug to help poorly growing fetuses are halted after infant deaths By Jop de VriezeJul. 25, 2018
Scientists beware: The price is high, the payoff uncertain at glossy publications aimed at Europe’s decision-makers By Jop de VriezeMar. 14, 2018
This new index ranks companies’ efforts in the fight against antimicrobial resistance By Jop de VriezeJan. 23, 2018
